Found 12 matching trials
The Clinical Study of SHR-A2009 for Injection in Patients With Advanced Solid Tumors
PHASE1This study is an open-label, phase I clinical trial of SHR-A2009 in patient...
Location
Chinese PLA General Hospital-Department of Medical Oncology
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
PHASE2The purpose of this study is to establish a prospective, multi-center platf...
Location
Breast cancer institute of Fudan University Cancer Hospital
A Phase IB/II Clinical Study of SHR-9839 for Injection Combined With Other Anti-tumor Therapies in Patients With Advanced Solid Tumors
PHASE1This study is an open-label, multicenter Phase IB/II clinical trial to eval...
Location
Henan Cancer Hospital
A Phase IB/II Clinical Study of SHR-A2009 for Injection in Combination With Other Antitumor Therapies in Patients With Advanced Solid Tumors
PHASE1This study is an open-label, multicenter Phase IB/II clinical trial to eval...
Location
Multiple Locations
A Phase Ib Study of HS-10504 Combined Therapy in NSCLC
PHASE1This is a multi-center, open-label, phase I study to evaluate the safety, e...
Location
Multiple Locations
A Study of SHR-A2009 Versus Platinum-based Chemotherapy in EGFR-mutated, Advanced or Metastatic NSCLC
PHASE3This study was a randomized, controlled, open-label, multicenter phase III ...
Status
Active Not Recruiting
Location
Guangdong Provincial People's Hospital
Study of HRS-8080 or SHR-A2009 Combined With Anti-tumor Therapy in Patients With Unresectable or Metastatic Breast Cancer
PHASE1This study is designed to determine if treatments with the combination of H...
Location
Hunan Cancer Hospital
Clinical Study of SHR-A1921 or SHR-A2009 in Previously Treated Advanced NSCLC
PHASE2This study is an open-label Phase II clinical trial to evaluate the safety ...
Location
Henan cancer hospital
Platform Study of ADC Rechallenge in ADC-treated Metastatic Breast Cancer
PHASE2This is a prospective, open-label, phase 2 platform trial. The purpose of t...
Location
Breast cancer institute of Fudan University Cancer Hospital
A Study of SHR-A2009 Combined With Aumolertinib Versus Aumolertinib for First-line Treatment in EGFR-mutated, Advanced or Metastatic NSCLC
PHASE3This study is a randomized, controlled, open-label, multicenter Phase III c...
Location
Guangdong Provincial People's Hospital